Merck CEO Kenneth Frazier Stepping Down
1 minuto de lectura
One prominent pharmaceutical company is about to swap out its CEO. Merck (NYSE: MRK) announced Thursday that its current leader, Kenneth Frazier, is retiring from his post, effective June 30. It did not provide any reason for his departure. He will be replaced by the company’s prRead MoreMarketsMarkets Feed
Descubre más desde Espacioteca
Suscríbete y recibe las últimas entradas en tu correo electrónico.
